title: The challenge of bleeding in antiphospholipid antibody-positive patients.
abstract: Antiphospholipid antibody-positive patients can develop bleeding due to capillaritis, microthrombosis, antiprothrombin antibodies, thrombocytopenia, and/or excessive antithrombotic therapy. Clinical characteristics of patients, e.g., renal impairment, elderly, or concomitant medications, are closely related to the risk of bleeding. The management of bleeding in antiphospholipid antibody (aPL)-positive patients is challenging due to the baseline increased risk of thrombosis. If anticoagulation is stopped, it should be restarted as soon as possible once the acute bleeding is controlled; the continuation of anticoagulation despite active bleeding may be required in selected cases. High-dose corticosteroid is the mainstay treatment for diffuse alveolar hemorrhage, lupus anticoagulant-hypoprothrombinemia syndrome, and severe thrombocytopenia; immunosuppressive drugs are also required to improve the long-term outcomes. Hydrocortisone is critical in adrenal hemorrhage patients due to concomitant adrenal insufficiency; despite bleeding, anticoagulation should be maintained as much as possible. Plasma exchange should be considered in catastrophic antiphospholipid syndrome patients with concurrent bleeding. This article will review the causes of bleeding in aPL-positive patients as well as the management strategies.
authors.affiliation: Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera Arcispedale S Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Viale Risorgimento n 80, 42100, Reggio Emilia, Italy, pazzola.giulia@asmn.re.it.
authors.forename: Giulia
authors.initials: G
authors.lastname: Pazzola
authors.forename: Stéphane
authors.initials: S
authors.lastname: Zuily
authors.forename: Doruk
authors.initials: D
authors.lastname: Erkan
mesh_terms: D000307:Adrenal Gland Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D016736:Antiphospholipid Syndrome / Q000150:complications*; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007020:Hypoprothrombinemias / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D011650:Pulmonary Alveoli